COMMUNIQUÉS West-GlobeNewswire

ChemoCentryx Strengthens Senior Executive Team with the Appointment of William Fairey as Executive Vice President and Chief Operating Officer

08/01/2018 - 14:30

MOUNTAIN VIEW, Calif., Jan. 08, 2018 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI ), a biopharmaceutical company developing new medications targeted at inflammatory and autoimmune diseases and cancer, today [...]

Immunomedics and Royalty Pharma Announce Royalty Funding and Stock Purchase Agreements Totalling $250 Million

08/01/2018 - 14:30

Royalty Pharma acquires Royalty Rights on Global Net Sales of Sacituzumab Govitecan (IMMU-132) Across All Indications for $175 Million Royalty Pharma Acquires $75 Million of Immunomedics Common Stock at $17.15 per share [...]

Argos Announces $1.5 Million Equity Investment by Lummy (Hong Kong), Ltd.

08/01/2018 - 14:30

DURHAM, N.C., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc. (NASDAQ: ARGS ), an immuno-oncology company focused on the development and commercialization of individualized immunotherapies based on the Arcelis [...]

ARCA biopharma Announces Completion of GENETIC-AF Phase 2B Clinical Trial

08/01/2018 - 14:30

-------------------------------------------------------------------------------------------------- GENETIC-AF Evaluating Gencaro as Potentially First Genetically-Targeted Treatment for Atrial Fibrillation [...]

Five Prime Therapeutics Earns IND Milestone Payment Under Immune Checkpoint Pathways Discovery Collaboration with Bristol-Myers Squibb and Announces that BMS has Extended the Research Term of this Collaboration for a Second Time

08/01/2018 - 14:30

Milestone for antibody targeting TIM-3 triggers $5 million payment to Five Prime BMS extends research collaboration term for discovery, development and commercialization for therapeutics in three immune checkpoint [...]

Cerner to Release Fourth Quarter 2017 Earnings Results February 6

08/01/2018 - 14:30

KANSAS CITY, Mo., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Cerner Corporation (Nasdaq: CERN ) today announced it will release its fourth quarter 2017 earnings results after the market closes Tuesday, Feb. 6. Following the [...]

HMS Appoints Two Healthcare Veterans to New Leadership Roles

08/01/2018 - 14:30

IRVING, Texas, Jan. 08, 2018 (GLOBE NEWSWIRE) -- HMS (NASDAQ: HMSY ) today announced that Emmet O’Gara and Michael Cole, two veteran healthcare executives, have joined HMS in newly created positions to help accelerate [...]

CareDx Reports Preliminary Fourth Quarter and FY2017 Financial Results

08/01/2018 - 14:30

BRISBANE, Calif., Jan. 08, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ: CDNA ), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value [...]

Oxford Immunotec Announces Preliminary Revenue for Fourth Quarter and Full Year 2017

08/01/2018 - 14:30

OXFORD, United Kingdom and MARLBOROUGH, Mass., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD ), a global, high-growth diagnostics company, today announced that based on preliminary [...]

Canada House Wellness Group Annual General Meeting Will be Held at 10 AM on 11th January 2018 in Pickering, Ontario

08/01/2018 - 14:28

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (CSE:CHV) (“ Canada House ” or the “ Company ”) wishes to [...]

Biomerica Signs Agreements with Beth Israel Deaconess & University of Michigan to Initiate Clinical Study for First of a Kind, Irritable Bowel Syndrome (IBS) Diagnostic Guided Therapy (DGT)

08/01/2018 - 14:19

- DGT Designed to identify patient specific foods, that when removed, may alleviate an individual's IBS symptoms - DGT can be used alongside current IBS drug treatments to potentially improve outcomes - Market research [...]

Allscripts to acquire Practice Fusion business

08/01/2018 - 14:01

CHICAGO, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX ), a global leader in healthcare technology, today announced a definitive agreement to acquire Practice Fusion, for $100 million in cash, subject to [...]

ZIVO Bioscience Subsidiary Wellmetris Selected to Present at Biotech Showcase During JPMorgan Healthcare Conference Jan 7-10 in San Francisco, CA

08/01/2018 - 14:00

KEEGO HARBOR, Mich., Jan. 08, 2018 (GLOBE NEWSWIRE) -- ZIVO Bioscience, Inc. (OTCMKTS:ZIVO), a biotech/agtech R&D company, announced today that its WellMetris subsidiary will be presenting at the Biotech Showcase at [...]

Adaptimmune Announces Two Manufacturing Achievements on Its way to Become the First Fully Integrated TCR T-cell Therapy Company

08/01/2018 - 14:00

PHILADELPHIA and OXFORD, United Kingdom, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq: ADAP ), a leader in T-cell therapy to treat cancer, today announced that it has successfully manufactured [...]

Teneobio Announces a Strategic Alliance with TESARO to Develop the Next Generation of Immuno-Oncology, Multispecific Antibodies

08/01/2018 - 14:00

MENLO PARK, Calif., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Teneobio, Inc., a next generation multi-specific antibody therapeutics company announced today the initiation of a research collaboration and licensing agreement [...]

AMAG Pharmaceuticals Announces Preliminary 2017 Financial Results and Provides 2018 Guidance

08/01/2018 - 14:00

WALTHAM, Mass., Jan. 08, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG ) today provided a business update, including preliminary unaudited fourth quarter and full year 2017 financial results and 2018 [...]

Athenex Announces Chinese FDA Allowance of Investigational New Drug Application of Oraxol to Begin Clinical Trials

08/01/2018 - 14:00

BUFFALO, N.Y., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX ), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]

REGENXBIO and AveXis Announce Expansion of Relationship through Amended License Agreement for the Development and Commercialization of Treatments for Spinal Muscular Atrophy

08/01/2018 - 14:00

AveXis acquires exclusive rights to entire NAV Technology Platform for the development of treatments for SMA Amended agreement permits assignment by AveXis upon a change of control without REGENXBIO’s consent REGENXBIO [...]

Sientra Announces Preliminary Unaudited Fourth Quarter 2017 Revenue

08/01/2018 - 14:00

Board Member Keith Sullivan Appointed Interim General Manager of miraDry Miramar Labs Officially Named miraDry, a Sientra Subsidiary Universal Shelf Registration Filed on Form S-3 SANTA BARBARA, Calif., Jan. 08, 2018 ( [...]